Cargando…

The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine

Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19) at both the individual and population levels. Vaccine hesitancy is identified as a significant threat to global health by the World Health Organization (WHO). Vaccine hesitancy has been theorized as a continuu...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Ramey, Purvis, Rachel S., Willis, Don E., Worley, Kyle C., Hervey, Devonte, Reece, Sharon, Yeates, Aimee, McElfish, Pearl A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747130/
https://www.ncbi.nlm.nih.gov/pubmed/36330587
http://dx.doi.org/10.1111/cts.13385
_version_ 1784849524039090176
author Moore, Ramey
Purvis, Rachel S.
Willis, Don E.
Worley, Kyle C.
Hervey, Devonte
Reece, Sharon
Yeates, Aimee
McElfish, Pearl A.
author_facet Moore, Ramey
Purvis, Rachel S.
Willis, Don E.
Worley, Kyle C.
Hervey, Devonte
Reece, Sharon
Yeates, Aimee
McElfish, Pearl A.
author_sort Moore, Ramey
collection PubMed
description Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19) at both the individual and population levels. Vaccine hesitancy is identified as a significant threat to global health by the World Health Organization (WHO). Vaccine hesitancy has been theorized as a continuum encompassing a range of attitudes, beliefs, emotional orientations, ideologies, and health‐seeking behaviors. Individuals who received the COVID‐19 vaccine but also indicated some level of hesitancy about vaccination, or “hesitant adopters,” remain an understudied group. This study uses a qualitative descriptive design to understand motivations to receive the COVID‐19 vaccine among hesitant adopters at various self‐reported levels of hesitancy. We conducted interviews with hesitant adopters (n = 49) to analyze the elements of vaccine hesitancy corresponding to reported levels of COVID‐19 vaccine hesitancy (i.e., “little hesitant,” “somewhat hesitant,” and “very hesitant”). Concerns about side effects are shared across the continuum but are articulated differently at each level of hesitancy. The “little hesitant” relate fears of side effects to their health and a lack of clear information to inform their health decision making, whereas the “very hesitant” articulate the risks of side effects within the frame of conspiracies related to the development, approval, and economics of the COVID‐19 vaccine. Additionally, conspiracy theories generally increase in salience across the continuum, with the “very hesitant” reporting conspiracy theories as the most salient element of vaccine hesitancy. This research presents opportunities for developing targeted interventions for different levels of vaccine hesitancy.
format Online
Article
Text
id pubmed-9747130
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97471302022-12-14 The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine Moore, Ramey Purvis, Rachel S. Willis, Don E. Worley, Kyle C. Hervey, Devonte Reece, Sharon Yeates, Aimee McElfish, Pearl A. Clin Transl Sci Research Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19) at both the individual and population levels. Vaccine hesitancy is identified as a significant threat to global health by the World Health Organization (WHO). Vaccine hesitancy has been theorized as a continuum encompassing a range of attitudes, beliefs, emotional orientations, ideologies, and health‐seeking behaviors. Individuals who received the COVID‐19 vaccine but also indicated some level of hesitancy about vaccination, or “hesitant adopters,” remain an understudied group. This study uses a qualitative descriptive design to understand motivations to receive the COVID‐19 vaccine among hesitant adopters at various self‐reported levels of hesitancy. We conducted interviews with hesitant adopters (n = 49) to analyze the elements of vaccine hesitancy corresponding to reported levels of COVID‐19 vaccine hesitancy (i.e., “little hesitant,” “somewhat hesitant,” and “very hesitant”). Concerns about side effects are shared across the continuum but are articulated differently at each level of hesitancy. The “little hesitant” relate fears of side effects to their health and a lack of clear information to inform their health decision making, whereas the “very hesitant” articulate the risks of side effects within the frame of conspiracies related to the development, approval, and economics of the COVID‐19 vaccine. Additionally, conspiracy theories generally increase in salience across the continuum, with the “very hesitant” reporting conspiracy theories as the most salient element of vaccine hesitancy. This research presents opportunities for developing targeted interventions for different levels of vaccine hesitancy. John Wiley and Sons Inc. 2022-11-03 2022-12 /pmc/articles/PMC9747130/ /pubmed/36330587 http://dx.doi.org/10.1111/cts.13385 Text en © 2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research
Moore, Ramey
Purvis, Rachel S.
Willis, Don E.
Worley, Kyle C.
Hervey, Devonte
Reece, Sharon
Yeates, Aimee
McElfish, Pearl A.
The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
title The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
title_full The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
title_fullStr The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
title_full_unstemmed The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
title_short The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
title_sort vaccine hesitancy continuum among hesitant adopters of the covid‐19 vaccine
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747130/
https://www.ncbi.nlm.nih.gov/pubmed/36330587
http://dx.doi.org/10.1111/cts.13385
work_keys_str_mv AT mooreramey thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT purvisrachels thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT willisdone thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT worleykylec thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT herveydevonte thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT reecesharon thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT yeatesaimee thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT mcelfishpearla thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT mooreramey vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT purvisrachels vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT willisdone vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT worleykylec vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT herveydevonte vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT reecesharon vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT yeatesaimee vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine
AT mcelfishpearla vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine